- Home
- COSM vs PSTV Comparison
COSM vs PSTV Comparison
Compare COSM & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- PSTV
- Stock Information
- Founded
- COSM 2009
- PSTV 1996
- Country
- COSM United States
- PSTV United States
- Employees
- COSM N/A
- PSTV N/A
- Industry
- COSM Other Pharmaceuticals
- PSTV Medical/Dental Instruments
- Sector
- COSM Health Care
- PSTV Health Care
- Exchange
- COSM Nasdaq
- PSTV Nasdaq
- Market Cap
- COSM 12.9M
- PSTV 10.4M
- IPO Year
- COSM 2013
- PSTV N/A
- Fundamental
- Price
- COSM $0.43
- PSTV $0.32
- Analyst Decision
- COSM
- PSTV Strong Buy
- Analyst Count
- COSM 0
- PSTV 3
- Target Price
- COSM N/A
- PSTV $10.83
- AVG Volume (30 Days)
- COSM 190.3K
- PSTV 67.2M
- Earning Date
- COSM 08-18-2025
- PSTV 08-13-2025
- Dividend Yield
- COSM N/A
- PSTV N/A
- EPS Growth
- COSM N/A
- PSTV N/A
- EPS
- COSM N/A
- PSTV N/A
- Revenue
- COSM $53,554,457.00
- PSTV $5,206,000.00
- Revenue This Year
- COSM $28.14
- PSTV $13.26
- Revenue Next Year
- COSM N/A
- PSTV $8.84
- P/E Ratio
- COSM N/A
- PSTV N/A
- Revenue Growth
- COSM N/A
- PSTV N/A
- 52 Week Low
- COSM $0.28
- PSTV $0.16
- 52 Week High
- COSM $1.58
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- COSM 45.07
- PSTV 47.17
- Support Level
- COSM $0.42
- PSTV $0.17
- Resistance Level
- COSM $0.47
- PSTV $0.44
- Average True Range (ATR)
- COSM 0.03
- PSTV 0.05
- MACD
- COSM -0.00
- PSTV 0.02
- Stochastic Oscillator
- COSM 21.56
- PSTV 55.39
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).